Genmab A/S (LON:0MGB)
London · Delayed Price · Currency is GBP · Price in DKK 2,180.48
-33.22 (-1.50%)
At close: Jan 16, 2026
Genmab Market Cap
Genmab has a market cap or net worth of 14.61 billion as of January 16, 2026. Its market cap has increased by 38.52% in one year.
Market Cap
14.61B
Enterprise Value
12.19B
Revenue
2.86B
Ranking
n/a
PE Ratio
12.40
Stock Price
2,180.48
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 287.00M to 14.61B, an increase of 4,989.13%. That is a compound annual growth rate of 16.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 14.61B | 0.06% |
| Dec 30, 2025 | 14.60B | 38.44% |
| Dec 30, 2024 | 10.54B | -35.66% |
| Dec 29, 2023 | 16.39B | -28.50% |
| Dec 30, 2022 | 22.92B | 18.07% |
| Dec 30, 2021 | 19.41B | -0.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.93B |
| HSBC Holdings | 211.24B |
| Shell | 156.98B |
| Rolls-Royce Holdings | 107.50B |
| Rio Tinto Group | 107.08B |
| Unilever | 105.43B |
| British American Tobacco p.l.c. | 93.93B |
| GSK plc | 72.88B |